{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:46:08Z","timestamp":1774619168975,"version":"3.50.1"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,5]],"date-time":"2019-05-05T00:00:00Z","timestamp":1557014400000},"content-version":"vor","delay-in-days":4,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tuberculosis"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.tube.2019.04.018","type":"journal-article","created":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T02:26:44Z","timestamp":1556245604000},"page":"S114-S117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"S","title":["The pathogenesis of post-primary tuberculosis. A game changer for vaccine development"],"prefix":"10.1016","volume":"116","author":[{"given":"Robert","family":"Hunter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Actor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tube.2019.04.018_bib1","series-title":"A new biology for the 21st century: ensuring the United States leads the coming biology revolution","author":"National_Research_Council","year":"2009"},{"key":"10.1016\/j.tube.2019.04.018_bib2","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/MMBR.68.2.173-186.2004","article-title":"A new biology for a new century","volume":"68","author":"Woese","year":"2004","journal-title":"Microbiol Mol Biol Rev : MMBR"},{"key":"10.1016\/j.tube.2019.04.018_bib3","series-title":"Tuberculosis: current concepts and treatment","first-page":"19","article-title":"Pathogenesis of tuberculosis","author":"Toossi","year":"2000"},{"key":"10.1016\/j.tube.2019.04.018_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1128\/CVI.00721-14","article-title":"Quest for correlates of protection against tuberculosis","volume":"22","author":"Bhatt","year":"2015","journal-title":"Clin Vaccine Immunol : CVI"},{"key":"10.1016\/j.tube.2019.04.018_bib5","series-title":"The pathogenesis of tuberculosis","author":"Rich","year":"1951"},{"key":"10.1016\/j.tube.2019.04.018_bib6","first-page":"1","article-title":"The behavior of pulmonary tuberculous lesions; a pathological study","volume":"71","author":"Medlar","year":"1955","journal-title":"Am Rev Tuberc"},{"key":"10.1016\/j.tube.2019.04.018_bib7","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1749-6632.1968.tb16691.x","article-title":"Biology of the mycobacterioses. Pathogenesis of tuberculosis in man","volume":"154","author":"Canetti","year":"1968","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.tube.2019.04.018_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fimmu.2018.02108","article-title":"The Pathogenesis of Tuberculosis: the early infiltrate of post-primary (adult pulmonary) tuberculosis - a distinct disease entity","volume":"9","author":"Hunter","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.tube.2006.11.003","article-title":"Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs","volume":"87","author":"Hunter","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2019.04.018_bib10","first-page":"145","article-title":"The interpretation of clinical pulmonary tuberculosis in terms of allergy","volume":"43","author":"Pottenger","year":"1927","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"10.1016\/j.tube.2019.04.018_bib11","series-title":"Pathogenesis of human pulmonary tuberculosis. Insights from the rabbit model","author":"Dannenberg","year":"2006"},{"key":"10.1016\/j.tube.2019.04.018_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.12688\/f1000research.13588.1","article-title":"Progress and challenges in TB vaccine development","volume":"7","author":"Voss","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.tube.2019.04.018_bib13","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.tube.2016.11.006","article-title":"Advances in basic and translational tuberculosis research: proceedings of the first meeting of RePORT international","volume":"102","author":"Geadas","year":"2017","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2019.04.018_bib14","doi-asserted-by":"crossref","first-page":"16076","DOI":"10.1038\/nrdp.2016.76","article-title":"Tuberculosis","volume":"2","author":"Pai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.tube.2019.04.018_bib15","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/S1473-3099(18)30421-3","article-title":"WHO preferred product characteristics for new vaccines against tuberculosis","volume":"18","author":"Schrager","year":"2018","journal-title":"The Lancet Infect Diseases"},{"key":"10.1016\/j.tube.2019.04.018_bib16","series-title":"Developing vaccines to prevent sustained infection with Mycobacterium tuberculosis: conference proceedings: november 7, 2014","author":"Schrager","year":"2015"},{"key":"10.1016\/j.tube.2019.04.018_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MTBP-0001-2016","article-title":"Breaking transmission with vaccines: the case of tuberculosis","volume":"5","author":"Gonzalo-Asensio","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2019.04.018_bib18","first-page":"S43","article-title":"Tricks to translating TB transcriptomics","volume":"3","author":"Deffur","year":"2015","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.tube.2019.04.018_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0012266","article-title":"Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas","volume":"5","author":"Mehra","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.04.018_bib20","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.tube.2014.06.004","article-title":"Immunoinformatics study on highly expressed Mycobacterium tuberculosis genes during infection","volume":"94","author":"Nguyen Thi le","year":"2014","journal-title":"Tuberculosis (Edinb)"},{"issue":"7","key":"10.1016\/j.tube.2019.04.018_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00014-18","article-title":"Identification and evaluation of novel protective antigens for the development of a candidate TB subunit vaccine","volume":"86","author":"Stylianou","year":"2018","journal-title":"Infect Immun"},{"key":"10.1016\/j.tube.2019.04.018_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nm.2285","article-title":"A multistage tuberculosis vaccine that confers efficient protection before and after exposure","volume":"17","author":"Aagaard","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.tube.2019.04.018_bib23","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1172\/JCI46252","article-title":"The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection","volume":"122","author":"Lin","year":"2012","journal-title":"J Clin Investig"},{"key":"10.1016\/j.tube.2019.04.018_bib24","article-title":"Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-gamma+ IL-2+ CD4+ and IFN-gamma+ CD8+ T cells","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.04.018_bib25","series-title":"Tuberculosis 2004","first-page":"459","article-title":"Pathogenesis of pulmonary tuberculosis: an interplay of tissue-damaging and macrophage-activating immmune responses. Dual mechanisms that control bacillary multiplication","author":"Dannenberg","year":"1994"},{"key":"10.1016\/j.tube.2019.04.018_bib26","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2012.11.007","article-title":"The evolutionary pressures that have molded Mycobacterium tuberculosis into an infectious adjuvant","volume":"16","author":"Russell","year":"2013","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.tube.2019.04.018_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/pathogens7010019","article-title":"Pathogenesis and animal models of post-primary (bronchogenic) tuberculosis, a review","volume":"7","author":"Hunter","year":"2018","journal-title":"Pathogens"},{"key":"10.1016\/j.tube.2019.04.018_bib28","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.TBTB2-0029-2016","article-title":"Pathology of tuberculosis: how the pathology of human tuberculosis informs and directs animal models","volume":"5","author":"Basaraba","year":"2017","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.tube.2019.04.018_bib29","doi-asserted-by":"crossref","DOI":"10.1128\/CMR.00021-18","article-title":"Incipient and subclinical tuberculosis: a clinical review of early stages and progression of infection","volume":"31","author":"Drain","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.tube.2019.04.018_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1054\/tube.2001.0287","article-title":"Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and Guinea pigs, but is due to a continuous host response to mycobacterial products","volume":"81","author":"Dannenberg","year":"2001","journal-title":"Tuberculosis (Edinb)"},{"key":"10.1016\/j.tube.2019.04.018_bib31","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1146\/annurev.immunol.22.012703.104635","article-title":"Immunity to tuberculosis","volume":"22","author":"North","year":"2004","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib32","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.4049\/jimmunol.160.4.1796","article-title":"Effects of aminoguanidine on latent murine tuberculosis","volume":"160","author":"Flynn","year":"1998","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib33","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.4049\/jimmunol.170.4.2046","article-title":"Persistence and turnover of antigen-specific CD4 T cells during chronic tuberculosis infection in the mouse","volume":"170","author":"Winslow","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib34","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1084\/jem.193.3.271","article-title":"The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice","volume":"193","author":"Mogues","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.tube.2019.04.018_bib35","doi-asserted-by":"crossref","first-page":"276fs278","DOI":"10.1126\/scitranslmed.aaa4730","article-title":"Tuberculosis vaccines: time for a global strategy","volume":"7","author":"Kaufmann","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.tube.2019.04.018_bib36","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/ajrccm.163.3.2003070","article-title":"Exogenous reinfection with tuberculosis on a European island with a moderate incidence of disease","volume":"163","author":"Caminero","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.tube.2019.04.018_bib37","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1056\/NEJM199910143411602","article-title":"Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment","volume":"341","author":"van Rie","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.tube.2019.04.018_bib38","first-page":"8","article-title":"Epidemiology of tuberculosis in koch centennial memorial","volume":"125","author":"Comstock","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.tube.2019.04.018_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043285","article-title":"Risk stratification of latent tuberculosis defined by combined interferon gamma release assays","volume":"7","author":"Corbiere","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.tube.2019.04.018_bib40","series-title":"Tuberculosis","first-page":"302","article-title":"Chapter 13. Relationship between delayed hypersensitivity and immunity in tuberculosis","author":"Youmans","year":"1979"},{"key":"10.1016\/j.tube.2019.04.018_bib41","series-title":"Pulmonary tuberculosis in the adult. Its fundamental aspects","author":"Pinner","year":"1945"},{"key":"10.1016\/j.tube.2019.04.018_bib42","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1016\/j.vaccine.2007.07.005","article-title":"Lactoferrin enhanced efficacy of the BCG vaccine to generate host protective responses against challenge with virulent Mycobacterium tuberculosis","volume":"25","author":"Hwang","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.tube.2019.04.018_bib43","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.2174\/138161209788453202","article-title":"Lactoferrin as a natural immune modulator","volume":"15","author":"Actor","year":"2009","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.tube.2019.04.018_bib44","first-page":"261","article-title":"Lactoferrin in health and disease","volume":"61","author":"Kruzel","year":"2007","journal-title":"Post\u0119py Higieny Medycyny Do\u015bwiadczalnej"},{"key":"10.1016\/j.tube.2019.04.018_bib45","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.3389\/fimmu.2017.01438","article-title":"Lactoferrin in a context of inflammation-induced pathology","volume":"8","author":"Kruzel","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib46","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/jlb.51.4.343","article-title":"Modulation of natural killer and lymphokine-activated killer cell cytotoxicity by lactoferrin","volume":"51","author":"Shau","year":"1992","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.tube.2019.04.018_bib47","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/intimm\/dxp084","article-title":"Lactoferrin modulation of BCG-infected dendritic cell functions","volume":"21","author":"Hwang","year":"2009","journal-title":"Int Immunol"},{"key":"10.1016\/j.tube.2019.04.018_bib48","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.biochi.2008.04.008","article-title":"Influence of bovine lactoferrin on expression of presentation molecules on BCG-infected bone marrow derived macrophages","volume":"91","author":"Hwang","year":"2009","journal-title":"Biochimie"},{"key":"10.1016\/j.tube.2019.04.018_bib49","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/0394632015599832","article-title":"CHO expressed recombinant human lactoferrin as an adjuvant for BCG","volume":"28","author":"Hwang","year":"2015","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.tube.2019.04.018_bib50","first-page":"487","article-title":"Immune activity of BCG infected mouse macrophages treated with a novel recombinant mouse lactoferrin","volume":"45","author":"O'Shea","year":"2015","journal-title":"Ann Clin Lab Sci"},{"key":"10.1016\/j.tube.2019.04.018_bib51","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1016\/j.vaccine.2009.03.036","article-title":"A novel recombinant human lactoferrin augments the BCG vaccine and protects alveolar integrity upon infection with Mycobacterium tuberculosis in mice","volume":"27","author":"Hwang","year":"2009","journal-title":"Vaccine"}],"container-title":["Tuberculosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921930157X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147297921930157X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:42:43Z","timestamp":1761468163000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147297921930157X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":51,"alternative-id":["S147297921930157X"],"URL":"https:\/\/doi.org\/10.1016\/j.tube.2019.04.018","relation":{},"ISSN":["1472-9792"],"issn-type":[{"value":"1472-9792","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pathogenesis of post-primary tuberculosis. A game changer for vaccine development","name":"articletitle","label":"Article Title"},{"value":"Tuberculosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tube.2019.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}